Patent US6314451B1 successfully refreshed from Google Patents.
US4152412A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Marking vaccine
Assignee: Fairleigh Dickinson Laboratories Inc
•
Filing: 1977-11-04
•
Granted: 1979-05-01
•
Expires: 1997-11-04
Abstract
Abstract A vaccine, toxoid or like agent is administered to an animal by injecting the agent (usually intracutaneously) on a physiologically acceptable colored particle, preferably activated charcoal, which has a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of the vaccine or toxoid, and a repository of immunologically active material to serve as a booster.
Inventors
- 👤 John H. Brewer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 06:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A01; A01K; A01K11/00; A61D; A61D1/00; A61D1/02; A61D1/025; A61B; A61B90/00; A61B90/39; A61B2090/3937
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
64 words
In the method of administering vaccines, antigens, toxoids or other immunizing agents to an animal, the improvement comprising: injecting an effective amount of the agent into the skin of the animal in conjunction with a physiologically acceptable colored particle having a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of said agent.
Claim 2
Dependent Claim
64 words
In the method of administering vaccines, antigens, toxoids or other immunizing agents to an animal, the improvement comprising: injecting an effective amount of the agent into the skin of the animal in conjunction with a physiologically acceptable colored particle having a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of said agent.
Claim 3
Dependent Claim
14 words
The method of claim 1 wherein the agent is adsorbed on said colored particle.
Claim 4
Dependent Claim
12 words
The method of claim 2 wherein the colored particle is activated charcoal.
Claim 5
Dependent Claim
18 words
The method of claim 3 wherein the colored particle has a particle size of at least 0.5 micron.
Claim 6
Dependent Claim
12 words
The method of claim 4 wherein the agent is in lysed form.
Claim 7
Dependent Claim
28 words
The method of claim 5 wherein the agent is administered as a combination of the whole organism and the agent in lysed form adsorbed on said activated charcoal.
Claim 8
Dependent Claim
12 words
The method of claim 4 wherein the agent is Brucella abortus vaccine.
Claim 9
Dependent Claim
11 words
The method of claim 4 wherein the agent is rabies vaccine.
Claim 10
Dependent Claim
11 words
The method of claim 4 wherein the agent is killed vaccine.
Claim 11
Dependent Claim
56 words
In a method of vaccinating an animal against Brucella abortus, the improvement comprising: injecting into the skin an effective amount of Brucella abortus vaccine adsorbed on a physiologically acceptable colored particle having a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of said vaccine.
Claim 12
Dependent Claim
56 words
In a method of vaccinating an animal against Brucella abortus, the improvement comprising: injecting into the skin an effective amount of Brucella abortus vaccine adsorbed on a physiologically acceptable colored particle having a particle size whereby the colored particle remains at the point of injection to provide a visible mark which evidences administration of said vaccine.
Claim 13
Dependent Claim
25 words
The method of claim 10 wherein the vaccine is in lysed form adsorbed on activated charcoal having a particle size of at least 0.5 micron.
Claim 14
Dependent Claim
55 words
A composition for vaccinating an animal, comprising: Brucella Abortus vaccine in lysed form, adsorbed on colored adsorbent particles, said vaccine being adsorbed on colored adsorbent particles having a particle size of at least 0.5 micron to provide upon injection a visible mark and a repository of the vaccine for release over a period of time.
Claim 15
Dependent Claim
55 words
A composition for vaccinating an animal, comprising: Brucella Abortus vaccine in lysed form, adsorbed on colored adsorbent particles, said vaccine being adsorbed on colored adsorbent particles having a particle size of at least 0.5 micron to provide upon injection a visible mark and a repository of the vaccine for release over a period of time.
Claim 16
Dependent Claim
12 words
The composition of claim 12 wherein the adsorbent particles are activated charcoal.
Claim 17
Dependent Claim
23 words
The composition of claim 13 wherein the activated charcoal was subjected to vacuum to remove adsorbed gases prior to adsorption of the vaccine.
References Cited (Backward Citations)
US2143088A
Cited
US2496270A
Cited
US2952585A
Cited
US3097141A
Cited
US3096249A
Cited
US3379176A
Cited
US3633584A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-04-30 | 1982-10-30 | 1983-05-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-04-30 | 1986-10-30 | 1987-05-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-04-30 | 1990-10-30 | 1991-05-01 | $7700.00 | Window Closed / Lapsed |